Generic placeholder image

Coronaviruses

Editor-in-Chief

ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Perspective Article

Yoga may Prevent Cytokine Storm in COVID-19

Author(s): Surabhi Gautam and Rima Dada*

Volume 2, Issue 3, 2021

Published on: 15 September, 2020

Page: [284 - 288] Pages: 5

DOI: 10.2174/2666796701999200915142830

Abstract

The pandemic outbreak of coronavirus disease (COVID-19) has emerged as the most threatening public health challenge. The clinical presentation ranges from asymptomatic and mild clinical symptoms to acute respiratory-distress syndrome (ARDS) and death. Apart from the respiratory system, other organ systems like cardiovascular, renal, and gastrointestinal systems are also involved. Cytokine storm is a condition of systemic inflammatory cytokine rampage through the bloodstream leading to lifethreatening complications. There is an urgent need for the prevention of infection and effective management. Yoga is a profound science with both immunity-boosting and immune-modulating capacity. We propose that yoga-based intervention may aid in improving health with its immunity-boosting potential and preventing the exuberant inflammatory cytokine storm, thus reducing the severity of the disease. It can also reduce stress, anxiety, and co-morbid depression by promoting neuroplasticity and prevents persistent activation of the hypothalamus pituitary adrenal axis and thus may reduce disease severity. It may also enhance the immunity of caretakers and make them more emotionally resilient. Thus, yoga can be useful for enhancing immunity, stress reduction and may prevent the exaggerated immune response to the cytokine storm.

Keywords: COVID-19, SARS-CoV-2, cytokine storm, yoga, inflammation, depression.

[1]
Guan W-J, Ni Z-Y, Hu Y, et al. China Medical treatment expert group for Covid-19. Clinical Characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[2]
Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 2019; 2019: 11.
[http://dx.doi.org/10.1186/s40779-020-00240-0]]
[3]
Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis 2020; 39(6): 1011-9.
[http://dx.doi.org/10.1007/s10096-020-03874-z] [PMID: 32291542]
[4]
Fu L, Wang B, Yuan T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect 2020; 80(6): 656-65.
[http://dx.doi.org/10.1016/j.jinf.2020.03.041] [PMID: 32283155]
[5]
Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 2020; 323(13): 1239-42.
[http://dx.doi.org/10.1001/jama.2020.2648] [PMID: 32091533]
[6]
Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect 2020; 80(6): 607-13.
[http://dx.doi.org/10.1016/j.jinf.2020.03.037] [PMID: 32283152]
[7]
Rizzo P, Sega FVD, Fortini F, et al. COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? Basic Res Cardiol 2020; 115(3): 31.
[http://dx.doi.org/10.1007/s00395-020-0791-5]
[8]
Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect 2020; 53(3): 368-70.
[http://dx.doi.org/10.1016/j.jmii.2020.03.005] [PMID: 32205092]
[9]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[10]
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8(5): 475-81.
[http://dx.doi.org/10.1016/S2213-2600(20)30079-5] [PMID: 32105632]
[11]
Tolahunase MR, Sagar R, Faiq M, Dada R. Yoga- and meditation-based lifestyle intervention increases neuroplasticity and reduces severity of major depressive disorder: a randomized controlled trial. Restor Neurol Neurosci 2018; 36(3): 423-42.
[http://dx.doi.org/10.3233/RNN-170810] [PMID: 29614706]
[12]
Tolahunase M, Sagar R, Dada R. Impact of yoga and meditation on cellular aging in apparently healthy individuals: a prospective, open-label single-arm exploratory study. Oxid Med Cell Longev 2017; 20177928981
[PMID: 28191278]
[13]
Gautam S, Tolahunase M, Kumar U, Dada R. Impact of yoga based mind-body intervention on systemic inflammatory markers and co-morbid depression in active Rheumatoid arthritis patients: a randomized controlled trial. Restor Neurol Neurosci 2019; 37(1): 41-59.
[http://dx.doi.org/10.3233/RNN-180875] [PMID: 30714983]
[14]
Gagrani M, Faiq MA, Sidhu T, et al. Meditation enhances brain oxygenation, upregulates BDNF and improves quality of life in patients with primary open angle glaucoma: a randomized controlled trial. Restor Neurol Neurosci 2018; 36(6): 741-53.
[http://dx.doi.org/10.3233/RNN-180857] [PMID: 30400122]
[15]
Lai C-C, Shih T-P, Ko W-C, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 2020; 55(3)105924
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105924] [PMID: 32081636]
[16]
Fülöp T, Dupuis G, Witkowski JM, Larbi A. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin 2016; 68(2): 84-91.
[PMID: 27103044]
[17]
Chalan P, van den Berg A, Kroesen B-J, Brouwer L, Boots A. Rheumatoid arthritis, immunosenescence and the hallmarks of aging. Curr Aging Sci 2015; 8(2): 131-46.
[http://dx.doi.org/10.2174/1874609808666150727110744] [PMID: 26212057]
[18]
Weyand CM, Goronzy JJ. Aging of the immune system. Mechanisms and therapeutic targets. Ann Am Thorac Soc 2016; 13(Suppl. 5): S422-8.
[http://dx.doi.org/10.1513/AnnalsATS.201602-095AW] [PMID: 28005419]
[19]
Gautam S, Kumar M, Goswami A, et al. Yoga and meditation based lifestyle intervention increases the levels of soluble human leukocyte antigen-G levels in men with rheumatoid arthritis: clinical implications. Fertil Steril 2018; 110e129
[http://dx.doi.org/10.1016/j.fertnstert.2018.07.385]
[20]
Gautam S, Kumar U, Kumar A, et al. Yoga and meditation based lifestyle intervention on rheumatoid arthritis: a pilot study. J Anat Soc India 2017; 66: S45.
[http://dx.doi.org/10.1016/j.jasi.2017.08.145]
[21]
Gerritsen RJS, Band GPH. Breath of life: the respiratory vagal stimulation model of contemplative activity. Front Hum Neurosci 2018; 12: 397.
[http://dx.doi.org/10.3389/fnhum.2018.00397]
[22]
Beutler E, Beltrami FG, Boutellier U, et al. Effect of regular yoga practice on respiratory regulation and exercise performance. PLoS One 2016; 11(4)e0153159
[23]
Soni R, Munish K, Singh K, Singh S. Study of the effect of yoga training on diffusion capacity in chronic obstructive pulmonary disease patients: a controlled trial. Int J Yoga 2012; 5(2): 123-7.
[http://dx.doi.org/10.4103/0973-6131.98230] [PMID: 22869996]
[24]
Yang ZY, Zhong HB, Mao C, et al. Yoga for asthma. Cochrane 105 Database Syst Rev 2016; 2016: 4CD010346
[http://dx.doi.org/10.1002/14651858.CD010346.pub2] [PMID: 27115477]
[25]
Prathikanti S, Rivera R, Cochran A, Tungol JG, Fayazmanesh N, Weinmann E. Treating major depression with yoga: a prospective, randomized, controlled pilot trial. PLoS One 2017; 12(3)e0173869
[http://dx.doi.org/10.1371/journal.pone.0173869] [PMID: 28301561]
[26]
Balaji R, Ramanathan M, Bhavanani AB, Ranganadin P, Balachandran K. Effectiveness of adjuvant yoga therapy in diabetic lung: a randomized control trial. Int J Yoga 2019; 12(2): 96-102.
[http://dx.doi.org/10.4103/ijoy.IJOY_20_18] [PMID: 31143016]
[27]
Dada T, Mittal D, Mohanty K, et al. Mindfulness meditation reduces intraocular pressure, lowers stress biomarkers and modulates gene expression in glaucoma: a randomized controlled trial. J Glaucoma 2018; 27(12): 1061-7.
[http://dx.doi.org/10.1097/IJG.0000000000001088] [PMID: 30256277]
[28]
Bisht S, Banu S, Srivastava S, et al. Sperm methylome alterations following yoga-based lifestyle intervention in patients of primary male infertility: a pilot study. Andrologia 2020; 52(4)e13551
[http://dx.doi.org/10.1111/and.13551] [PMID: 32124461]
[29]
Dhawan V, Kumar M, Deka D, et al. Meditation & yoga: Impact on oxidative DNA damage & dysregulated sperm transcripts in male partners of couples with recurrent pregnancy loss. Indian J Med Res 2018; 148(Suppl.): S134-9.
[PMID: 30964091]
[30]
Sharp J. Coping with coronavirus anxiety 2020. Available from: https://www.health.harvard.edu/blog/coping-with-coronavirus-anxiety-2020031219183
[31]
Rima D, Shiv BK, Bhavna Ch, Shilpa B, Saima Kh. Oxidative stress induced damage to paternal genome and impact of meditation and yoga - can it reduce incidence of childhood Cancer? Asian Pac J Cancer Prev 2016; 17(9): 4517-25.
[PMID: 27880996]
[32]
Qu S, Olafsrud SM, Meza-Zepeda LA, Saatcioglu F. Rapid gene expression changes in peripheral blood lymphocytes upon practice of a comprehensive yoga program. PLoS One 2013; 8(4)e61910
[http://dx.doi.org/10.1371/journal.pone.0061910] [PMID: 23613970]
[33]
Bhasin MK, Dusek JA, Chang B-H, et al. Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS One 2013; 8(5)e62817
[http://dx.doi.org/10.1371/journal.pone.0062817] [PMID: 23650531]
[34]
Harinath K, Malhotra AS, Pal K, et al. Effects of Hatha yoga and Omkar meditation on cardiorespiratory performance, psychologic profile, and melatonin secretion. J Altern Complement Med 2004; 10(2): 261-8.
[http://dx.doi.org/10.1089/107555304323062257] [PMID: 15165407]
[35]
Zhang R, Wang X, Ni L, et al. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci 2020; 250117583
[http://dx.doi.org/10.1016/j.lfs.2020.117583] [PMID: 32217117]

© 2024 Bentham Science Publishers | Privacy Policy